GlassScriptPhysician profile
Keith Bennett Owen
NPI 1538178132
$2,631.67
in general payments reported to CMS, 2019-2025
19 companies · $457 in 2025
The $457 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $213 · 2021: $232 · 2022: $487 · 2023: $434 · 2024: $489 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $665.59 | 2019-2024 | Jornay Pm |
| Corium, LLC | $354.20 | 2022-2025 | Azstarys |
| Tris Pharma INC | $292.01 | 2019-2023 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $224.02 | 2021-2025 | Qelbree, Qelbree |
| Collegium Pharmaceutical, INC. | $212.07 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $187.66 | 2024-2025 | |
| Kaleo, INC. | $118.73 | 2019-2022 | |
| Neos Therapeutics, LP | $92.42 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $75.86 | 2021-2022 | |
| Adlon Therapeutics L.P. | $65.78 | 2019-2020 | |
| Pfizer INC. | $59.46 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $59.22 | 2021-2023 | Gardasil 9, Vaxelis, M-M-R II |
| Astrazeneca Pharmaceuticals LP | $58.90 | 2023-2024 | Flumist Quadrivalent |
| Shire North American Group INC | $46.06 | 2019 | |
| Genentech USA, INC. | $38.39 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $29.83 | 2025 | Flucelvax |
| Sanofi Pasteur INC. | $19.16 | 2022 | |
| Verrica Pharmaceuticals INC. | $16.27 | 2024 | Ycanth |
| Sobi, INC | $16.04 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Owen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.